Syntaxin-6, a Reliable Biomarker for Predicting the Prognosis of Patients with Cancer and the Effectiveness of Immunotherapy

SIMPLE SUMMARY: The treatment of cancer may differ on the basis of whether it is detected early or late, which determines whether the disease has spread, as well as treatment choices. Therefore, early detection is crucial in cancer therapy to increase overall patient survival and lessen the financia...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenchao, Li, Kuan, Wei, Hongfa, Sun, Yu, Liao, Yangjing, Zou, Yuan, Chen, Xiancong, Deng, Cuncan, Chen, Songyao, He, Yulong, Huo, Mingyu, Zhang, Changhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817965/
https://www.ncbi.nlm.nih.gov/pubmed/36612024
http://dx.doi.org/10.3390/cancers15010027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817965/
https://www.ncbi.nlm.nih.gov/pubmed/36612024
http://dx.doi.org/10.3390/cancers15010027

Ejemplares similares